logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore

prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Zydus Wellness Ltd

Zydus Wellness

Mid Cap1,008 EmployeesIPO 1995
Current Price
380.95
-3.35 (-0.87%)Updated
NSE :ZYDUSWELL
BSE :531335
Valuation vs Sector
P/E Ratio
58.09vs 35.78
P/B Ratio
2.11vs 8.88
Div Yield
0.29%vs 1.66%
Today's Range
376.9
380.95
indicator
388.6
52 Week Range
52W Low367.55
52W High2625.00
380.95
indicator
Downside3.65%
Upside589.07%

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
12,975.94 Cr
Market Cap
Total market value of company
P/E Ratio
62.66
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
2.55
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
6.48
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
2.09%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
6.16%
ROCE
Return on Capital Employed. >15% is good
Net Margin
6.11%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
-14.90%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
26.31%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
32.00%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
-257.00%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.03
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
178.26
Book Value
Net asset value per share
Dividend Yield
0.29%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
69.60%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • Promoter holding of 69.6% indicates strong insider confidence.
  • Very low debt-to-equity ratio of 0.03 ensures financial stability.

Weaknesses

5 points
  • Latest quarterly profit declined by -13.40%, signaling profitability challenges.
  • Negative 5-year EPS growth of -14.90% indicates earnings contraction.

Opportunities

5 points
  • Growing consumer demand, urbanization, rising incomes drive packaged food sector.
  • Innovating and expanding health and wellness product lines can unlock revenue.

Threats

5 points
  • Faces strong competition from established players like Nestle and Britannia.
  • Fluctuations in raw material prices pose a threat to operating margins.

Segment-wise Financial Analysis

Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

Recent Insider Transactions

Insider NameTransaction DateFiling DateTotal SharesChangePriceAction
THREPSI CARE LLP
27 Dec 202401 Jan 202546.33 L
1.07 L
₹1,892.45SELL
THREPSI CARE LLP
30 Dec 202402 Jan 202546.27 L
5,735
₹1,892.46SELL
Vijay Uttarwar
04 Mar 202507 Mar 2025589
589
₹1,535.9BUY
Vijay Uttarwar
12 Mar 202513 Mar 20251,690
1,101
₹1,593.34BUY
Umesh Vinodray Parikh
13 Mar 202517 Mar 20251,106
1,100
₹1,596.15BUY
Vijay Uttarwar
17 Mar 202518 Mar 20252,500
810
₹1,580BUY
Manoj Kothari
19 Mar 202520 Mar 20251,050
200
₹1,658.98BUY
Manoj Kothari
19 Mar 202520 Mar 2025850
250
₹1,658.42BUY
Umesh Vinodray Parikh
21 Mar 202524 Mar 20252,506
1,400
₹1,665.44BUY
Vijay Uttarwar
25 Mar 202526 Mar 20255,000
2,500
₹1,669.64BUY
Manoj Kothari
27 Mar 202528 Mar 20251,124
15
₹1,606.53BUY
Manoj Kothari
27 Mar 202528 Mar 20251,109
59
₹1,608.73BUY
Ganesh N. Nayak
22 May 202523 May 202511,926
5,376
₹1,971.18BUY
Rupa Nitin Parekh
26 May 202527 May 20251,584
416
₹1,975SELL
Rupa Nitin Parekh
28 May 202529 May 20251,565
19
₹1,950SELL
Rupa Nitin Parekh
29 May 202530 May 20251,065
500
₹1,950SELL
Rupa Nitin Parekh
02 Jun 202503 Jun 2025565
500
₹1,980SELL
Dhaval Narendra Soni HUF
05 Jun 202509 Jun 202550
50
₹1,894.1BUY
Rupa Nitin Parekh
10 Jun 202511 Jun 2025-
565
₹1,950SELL

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4410.80+₹29.85+7.84%
R3399.10+₹18.15+4.76%
R2393.85+₹12.90+3.39%
R1387.40+₹6.45+1.69%
PIVOT382.151.200.32%
CURRENT380.95--
S1352.30-₹28.65-7.52%
S2364.00-₹16.95-4.45%
S3370.45-₹10.50-2.76%
S4375.70-₹5.25-1.38%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
0.70L
(11 Mar 2026)
-32.7% vs avg
Delivery %
48.3%
(11 Mar 2026)
-1.7% vs avg
Avg Volume (20D)
1.03L
(11 Feb - 11 Mar)
20-day average
Avg Delivery %
50.0%
(11 Feb - 11 Mar)
Trend ↑
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Nestle India Ltd
2.48L ₹ Cr
Best Profit Growth
Manorama Industries Ltd
107.00 %
Highest Dividend Yield
Bombay Burmah Trading Corporation Ltd
7.99 %

Peer Comparison

Company Name
AVANTIFEED
Avanti Feeds Ltd
AWL
AWL Agri Business Ltd
BALRAMCHIN
Balrampur Chini Mills Ltd
BBTC
Bombay Burmah Trading Corporation Ltd
BIKAJI
Bikaji Foods International Ltd
CCL
CCL Products (India) Ltd
HATSUN
Hatsun Agro Product Ltd
KRBL
KRBL Ltd
LTFOODS
L T Foods Ltd
MANORAMA
Manorama Industries Ltd
MARICO
Marico Ltd
NESTLEIND
Nestle India Ltd
ORKLAINDIA
PATANJALI
Patanjali Foods Ltd
TRIVENI
Triveni Engineering and Industries Ltd

About

ZYDUSWELL

Zydus Wellness Ltd

Zydus Wellness Limited is a prominent Indian company specializing in the development, manufacturing, marketing, and distribution of a diverse portfolio of health and wellness products. Their operations span the entire value chain, from product conception to reaching consumers both domestically and internationally through exports. The company's extensive product line caters to a wide range of consumer needs and preferences, showcasing a commitment to offering choices within various health and wellness segments.

A significant portion of Zydus Wellness's business focuses on sugar substitutes. Under the Sugar Free brand umbrella (including variants like Sugar Free Gold, Natura, and Green), they offer a variety of products catering to individuals seeking healthier alternatives to traditional sugar. This segment highlights the company's responsiveness to evolving consumer health consciousness and the growing demand for sugar-free options.

Beyond sugar substitutes, Zydus Wellness boasts a strong presence in other key health and wellness categories. Complan, a milk-based health food drink, and Glucon-D, a glucose-based beverage, contribute substantially to their revenue streams, targeting consumers seeking nutritional supplements and energy boosts. Furthermore, their product portfolio includes I'm lite, a blended sugar coated with stevia, presenting another choice in the healthy sweetener market.

The company also holds a significant position in the personal care sector through established brands. Everyuth provides a range of skincare solutions including face washes, masks, and scrubs, while Nycil offers products addressing prickly heat, cooling needs, and hand hygiene. These diverse offerings demonstrate the company’s strategic diversification across related consumer product categories.

Finally, Zydus Wellness's Nutralite brand focuses on a selection of food products designed for health-conscious consumers. Their offerings include various spreads, such as probiotic butter, table spreads, ghee, and cholesterol-free alternatives, along with mayonnaise and chocolate spread. This segment indicates an expansion into the food sector with a health and wellness-oriented approach, aligning with their overall corporate strategy.

COMPANY FACTS - ZYDUSWELL

Registered Address

Zydus Corporate Park, Plot No. 103, Nr. Nirma University, Mouje - Khoraj, Sarkhej - Gandhinagar Hwy,

Ahmedabad

GUJARAT

IN

Company Details

Group: Food, Beverage & Tobacco

Sector: Consumer Staples

Industry: Food Products

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 1,008

IPO Date: 16/10/1995

MANAGEMENT - ZYDUSWELL

Dr. Sharvil Patel

Non-Executive Chairman of the Board

Mr. Tarun Arora

Chief Executive Officer, Whole Time Director

Mr. Umesh Parikh

Chief Financial Officer

Mr. Nandish Joshi

Company Secretary, Compliance Officer

Mr. Ganesh Nayak

Non-Executive Director

Mr. Kulin Lalbhai

Non-Executive Independent Director

Mr. Akhil Monappa

Non-Executive Independent Director

Mr. Srivishnu Nandyala

Non-Executive Independent Director

Ms. Dharmishta Raval

Non-Executive Woman Independent Director

Investor Questions Answered

Zydus Wellness Ltd (ZYDUSWELL) Stock FAQs

Get answers to the most common questions about Zydus Wellness Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Zydus Wellness Ltd (ZYDUSWELL) is ₹380.95. Today, the stock has declined by ₹3.35 (0.87%), trading in a range of ₹376.9 to ₹388.6. The stock opened at ₹388.6 with a trading volume of 13,555 shares.
Zydus Wellness Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹12,975.94 crores, P/E ratio of 62.66, ROE of 2.09%, and ROCE of 6.16%. The dividend yield stands at 0.29%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Zydus Wellness Ltd (ZYDUSWELL) is ₹2,625, while the 52-week low is ₹367.55. Currently trading at ₹380.95, the stock is 0.6% away from its 52-week low and 85.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Zydus Wellness Ltd stock at ₹380.95 depends on multiple factors. The stock is currently trading with a P/E ratio of 62.66 and P/B ratio of N/A. Today's performance shows a loss of 0.87%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Zydus Wellness Ltd offers a dividend yield of 0.29%, which means for every ₹100 invested at the current price of ₹380.95, you can expect to receive approximately ₹0.29 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Zydus Wellness Ltd's key financial metrics include: P/E Ratio: 62.66, P/B Ratio: N/A, ROE: 2.09%, ROCE: 6.16%, Dividend Yield: 0.29%, EPS: ₹6.48, Book Value: ₹178.26, Debt-to-Equity: 0.03, and Current Ratio: N/A. The company's market cap stands at ₹12,975.94 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Zydus Wellness Ltd stock opened at ₹388.6 and is currently trading at ₹380.95, showing a decline of ₹3.35 (0.87%). The intraday high is ₹388.6 and low is ₹376.9. The trading volume stands at 13,555 shares, indicating moderate market participation today.
Zydus Wellness Ltd has a Price-to-Earnings (P/E) ratio of 62.66, which means investors are willing to pay ₹62.66 for every ₹1 of earnings. With an EPS of ₹6.48, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Zydus Wellness Ltd has a market capitalization of ₹12,975.94 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹380.95) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Zydus Wellness Ltd has a book value of ₹178.26 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹380.95, which is 113.7% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Zydus Wellness Ltd has a Return on Equity (ROE) of 2.09% and Return on Capital Employed (ROCE) of 6.16%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Zydus Wellness Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Zydus Wellness Ltd has a debt-to-equity ratio of 0.03, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Zydus Wellness Ltd has an Earnings Per Share (EPS) of ₹6.48, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹380.95 and P/E ratio of 62.66, investors are paying 62.66 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Zydus Wellness Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Zydus Wellness Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Zydus Wellness Ltd stock, consider: 1) Fundamental Analysis - Review P/E (62.66), ROE (2.09%), debt-to-equity (0.03), and growth rates. 2) Technical Analysis - Check 52-week range (₹367.55 - ₹2625.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹380.95) with book value (₹178.26) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Zydus Wellness Ltd share is ₹2.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹380.95 is 18948x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Zydus Wellness Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹367.55 - ₹2625.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.03 indicates leverage. 4) Liquidity Risk - Based on trading volume of 13,555 shares. 5) Valuation Risk - P/E of 62.66 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Zydus Wellness Ltd operates in the industry with key metrics: P/E ratio of 62.66, ROE of 2.09%, market cap of ₹12,975.94 crores, and dividend yield of 0.29%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.03), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Zydus Wellness Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹380.95, with a 52-week range of ₹367.55 to ₹2625.00. Based on fundamentals like P/E (62.66), ROE (2.09%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Zydus Wellness Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹380.95. 2) Fundamental Deterioration - Declining ROE (currently 2.09%), increasing debt (D/E: 0.03), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Zydus Wellness Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.29%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.